Metabolic syndrome and comorbidities in patients with psoriasis: a community-based case-control study from the Nagahama cohort in Japan

被引:1
|
作者
Endo, Yuichiro [1 ,2 ]
Tabara, Yasuharu [3 ]
Kawaguchi, Takahisa [3 ]
Onoufriadis, Alexandros [2 ]
McGrath, John A. [2 ]
Matsuda, Fumihiko [3 ]
Kabashima, Kenji [1 ]
机构
[1] Kyoto Univ, Dept Dermatol, Kyoto, Japan
[2] Kings Coll London, St Johns Inst Dermatol, Sch Basic & Med Biosci, London, England
[3] Kyoto Univ, Ctr Genom Med, Kyoto, Japan
基金
日本科学技术振兴机构;
关键词
Community-based cohort; comorbidities; Japan; metabolic syndrome (MetS); psoriasis; OBSTRUCTIVE PULMONARY-DISEASE; ATOPIC-DERMATITIS; PREVALENCE; ONYCHOMYCOSIS; EPIDEMIOLOGY; METAANALYSIS; ASSOCIATION; DEPRESSION; ONSET;
D O I
10.1684/ejd.2022.4231
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background Psoriasis is reported to be associated with systemic diseases, such as metabolic syndrome (MetS), which is related to high blood pressure, hyperglycaemia, obesity and dyslipidaemia. However, clinical factors associated with psoriasis in the general population have not been fully elucidated. Objectives To explore the clinical factors associated with psoriasis by analysing a dataset of community-based cohort studies Materials & Methods The study participants consisted of 9,183 apparently healthy community residents in Japan (mean age: 64.5 +/- 10.7 years). The clinical parameters used in this study were obtained from a baseline investigation performed between 2008 and 2010. The history of psoriasis was queried using a structured questionnaire Results A total of 335 participants (3.6%) had a history of psoriasis. The psoriasis group was older (64.5 +/- 10.7 vs 57.9 +/- 12.3 years; p < 0.001) and mostly male (43.9 vs 33.0 %, p < 0.001) compared to the non-psoriasis group. Based on univariate analysis, the prevalence of MetS was higher in the psoriasis group (19.1 vs 13.6%, odds ratio = 1.50, p = 0.004), although this association disappeared after adjustment for age and sex. Similar results were observed based on the analysis of each MetS component. Other factors associated with psoriasis were history of tinea pedis (age-and sex-adjusted odds ratio = 5.27), gout (1.97), chronic obstructive pulmonary disease (5.83), reflux oesophagitis (1.72) and depressive symptoms (1.57). After further adjustment for potential covariates, the associations with these factors remained significant. Conclusion Several chronic conditions associated with psoriasis in the general population were identified
引用
收藏
页码:86 / 93
页数:8
相关论文
共 50 条
  • [1] Metabolic syndrome and comorbidities in patients with psoriasis: a community-based case-control study from the Nagahama cohort in Japan
    Yuichiro Endo
    Yasuharu Tabara
    Takahisa Kawaguchi
    Alexandros Onoufriadis
    John A. McGrath
    Fumihiko Matsuda
    Kenji Kabashima
    European Journal of Dermatology, 2022, 32 : 86 - 93
  • [2] Systemic comorbidities in patients of psoriasis: a case-control study from India
    Chavhan, Samiksha
    Jawade, Sugat
    Madke, Bhushan
    Singh, Adarsh Lata
    EGYPTIAN JOURNAL OF DERMATOLOGY AND VENEREOLOGY, 2023, 43 (01): : 67 - 74
  • [3] Psoriasis and comorbidities in a southern Brazilian population: a case-control study
    Menegon, Doris B.
    Pereira, Ana G.
    Camerin, Anna C.
    Cestari, Tania
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2014, 53 (11) : E518 - E525
  • [4] Residents' awareness and attitudes about an ongoing community-based genome cohort study in Nagahama, Japan
    Miyamoto, Keiko
    Iwakuma, Miho
    Nakayama, Takeo
    PUBLIC UNDERSTANDING OF SCIENCE, 2015, 24 (08) : 957 - 969
  • [5] Prevalence of Metabolic Syndrome in Chinese Patients With Erythrodermic Psoriasis: A Case-Control Study
    Ma, An-ran
    Liu, Fang
    Wang, Runnan
    Lin, Lanmei
    Wang, Yilun
    Li, Qunyi
    Lu, Xiaonian
    Du, Juan
    FRONTIERS IN ENDOCRINOLOGY, 2021, 12
  • [6] Investigation of Cardiovascular Disease and Metabolic Syndrome Risk with Copeptin in Psoriasis Patients: A Case-Control Study
    Agirgol, Senay
    Akbulut, Tugba Ozkok
    Demir, Filiz Topaloglu
    Cakir, Evrim
    Gumus, Alper
    Agirgol, Muharrem
    Turkoglu, Zafer
    Caytemel, Ceyda
    HASEKI TIP BULTENI-MEDICAL BULLETIN OF HASEKI, 2022, 60 (03): : 270 - 275
  • [7] Metabolic Syndrome and Psoriasis: A Case-Control Study in Kabul, Afghanistan
    Aalemi, Ahmad Khalid
    Bahain, Mohammad Barin
    Hamdard, Abdul Ghafar
    DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY, 2021, 14 : 1465 - 1471
  • [8] Comorbidities in Patients with Primary Sjogren's Syndrome: A Registry-based Case-control Study
    Kang, Jiunn-Horng
    Lin, Herng-Ching
    JOURNAL OF RHEUMATOLOGY, 2010, 37 (06) : 1188 - 1194
  • [9] Obesity and dyslipidemia in patients with psoriasis A case-control study
    Miao, Chaoyang
    Li, Jing
    Li, Ying
    Zhang, Xiaoyan
    MEDICINE, 2019, 98 (31)
  • [10] Risk factors for comorbidities in Czech psoriatic patients: Results of a hospital-based case-control study
    Votrubova, Jana
    Juzlova, Katerina
    Smerhovsky, Zdenek
    Fialova, Jorga
    Gopfertova, Dana
    Vojackova, Nadezda
    Hercogova, Jana
    BIOMEDICAL PAPERS-OLOMOUC, 2014, 158 (02): : 288 - 294